Project Grant R01DE034804
Award Date
5/1/25
Completion Date
1/31/30
Dollars Obligated
$582K
Federal Agency
National Institute of Dental and Craniofacial Research
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) provides $675,684 to investigate the microbial ecosystem surrounding dental implants and its relationship to peri-implantitis disease. The project aims to create a functional atlas of the peri-implant sulcus microbiome from inception to disease establishment, pinpoint timelines for breakdown of host-microbiome mutualism, and...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), aims to develop a multi-functional, antibacterial, and bioactive 3D-printed dental implant to prevent peri-implantitis. The primary objectives are to: 1) determine the processing-structure-property relationships of the 3D-printed implant material, 2) evaluate the infection resistance and osseointegration properties of...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under its Oral Diseases and Disorders Research program (CFDA 93.121) provides $434,746 to Nova Southeastern University, Inc. to investigate the impact of diabetes-induced hyperglycemia on the development of peri-implantitis, a common complication following dental implant placement. The project aims to elucidate the mechanisms by which hyperglycemia leads to changes in the oral microbiome and promotes...
The National Institute of Dental and Craniofacial Research (NIDCR), through the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121), awarded a $513,574 Project Grant to the Regents of the University of Michigan. The award, with an effective date of August 7, 2024 and a planned completion date of July 31, 2025, aims to elucidate the mechanisms underlying osteonecrosis of the jaw (ONJ), a serious condition associated with anti-resorptive medications used to treat cancer and...
The National Institute of Dental and Craniofacial Research (NIDCR), part of the Department of Health and Human Services, awarded a $847,000 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to the University of Utah. The 2-year grant, awarded on August 1, 2023, will fund research to develop and evaluate the efficacy of a novel antimicrobial bone scaffold made from zinc-doped fluorapatite for use in craniofacial surgical applications. The research aims to...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $226,500 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to The Medical University of South Carolina. The goal of this 2-year research project is to define how oral pathogens affect aging-associated immune responses and determine if inhibition of the CD38 enzyme can alleviate inflammatory bone loss and aging-associated immune responses induced by oral bacteria. The researchers will...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $169,242 project grant under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121) to the University of North Carolina at Chapel Hill. The grant, awarded on July 1, 2024, will fund a 5-year research project led by Dr. Adam Lietzan, a periodontist and research assistant professor, to study the role of interleukin-37 (IL-37) in modulating inflammatory responses in periodontal disease. The research...
This $656,315 Project Grant was awarded on September 1, 2024 by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121). The overarching goal is to mechanistically study the effect of biomaterial cyclic strain on the pathogenesis of oral microbes, including the fungal strain Candida albicans and denture-related microbiota. The research aims to understand how chewing actions may fuel the progression of...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $800,000 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to Rutgers, The State University of New Jersey. The objective of this 1-year grant, with a start date of June 5, 2024, is to elucidate how the matrix metalloproteinase 13 (MMP13) protein regulates the dental pulp's reparative processes and the inflammatory response in acute pulpitis. The research project will leverage conditional...
The federal Project Grant award R43DE034602, totaling $306,868.00, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The grant supports Cayman Chemical Co Inc., a for-profit manufacturer located in Ann Arbor, Michigan, in developing novel small molecule pharmacotherapies that inhibit the epigenetic enzyme EZH2 to stimulate alveolar bone formation and regeneration. The objective is to create...